Relationship between high prolactine levels and migraine attacks in patients with microprolactinoma

Domenico Bosco, Antonino Belfiore, Antonietta Fava, Marisa De Rose, M. Plastino, C. Ceccotti, Pasquale Mungari, Rosario Iannacchero, Angelo Lavano

The Journal of Headache and Pain · 2008 · 50 citations · 19 references

DOIFull text

Open access

Concepts

Abstract

The pathophysiology of pituitary-associated headache is unknown, although structural and functional features of the tumour are proposed mechanisms. The objective of this study was to evaluate whether headache in a population with pituitary micro-adenomas was related to hyperprolactinemia. We recruited 29 patients with microprolactinoma and headache: 16 with migraine (group A) and 13 with tension-type-headache (group B). The prolactin (PRL) levels measured during attacks of headache were significantly higher in nine patients (56%) of group A and in one patient (8%) of group B. In four of the nine patients of group A, PRL increased after thyrotropin-releasing-hormone (TRH) test and induced severe attacks. After dopamine-agonist (DA) treatment, the headache improved in seven (44%) patients of the group A and in two (15%) patients of the group B. Three of the four patients in whom the TRH-test induced headache attacks, improved after DA treatment. We suggest that hyperprolactinemia may contribute to development of pain in migraine subgroups and further TRH-test could be used to predict which patients could benefit by DA therapy.

References

19